# Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol

> **NCT03868202** · PHASE2 · UNKNOWN · sponsor: **Eastern Virginia Medical School** · enrollment: 10 (estimated)

## Conditions studied

- Follicle Stimulating Hormone Glycosylation
- Urinary FSH21/FSH24 Ratio
- Estradiol Effect

## Interventions

- **DRUG:** Estradiol Transdermal Product

## Key facts

- **NCT ID:** NCT03868202
- **Lead sponsor:** Eastern Virginia Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-03
- **Primary completion:** 2019-11
- **Final completion:** 2020-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2019-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868202, "Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03868202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*